ASLN

ASLAN Pharmaceuticals Share Price - ASLN

2.16
0.09 (4.35%)
Upgrade to Real-Time
Regular Market
2.16
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
ASLAN Pharmaceuticals Ltd ASLN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.09 4.35% 2.16 11:27:00
Open Price Low Price High Price Close Price Prev Close
2.26 2.12 2.26 2.07
Bid Price Ask Price Spread News
2.16 2.17 0.01 - 1
Trades Volume VWAP Dollar Volume Avg Volume
1,652 938,111  2.17  2,039,444 410,200
Last Trade Time Type Quantity Stock Price Currency
11:27:00 100  2.16 USD

ASLAN Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 82.06M 37.99M 37.99M  3.00M  - -1.45 -1.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News ASLAN Pharmaceuticals

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

ASLN Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology and oncology-focused biopharmaceutical company. It is engaged in developing treatments to transform the lives of patients. The company has a clinical portfolio comprised of a first in class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology.


Your Recent History
NASDAQ
ASLN
ASLAN Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.